9 3 5213 (Hydrochlorothiazide-Moexipril 12.5 mg / 7.5 mg)

Pill with imprint 9 3 5213 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 9 3 5213

Hydrochlorothiazide and moexipril hydrochloride

Imprint:

9 3 5213

Strength:

12.5 mg / 7.5 mg

Color:

Yellow

Size:

10.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

ACE inhibitors with thiazides

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Teva Pharmaceuticals USA

Inactive Ingredients:

lactose monohydrate
magnesium stearate
povidone k29/32
sodium bicarbonate
polyethylene glycol 3350
polyvinyl alcohol
magnesium silicate
titanium dioxide
FD&C Yellow No. 5
aluminum oxide
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
42291-0576	AvKare, Inc.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.